ArticleCureus2025
Autoeczematization: A Rare Complication of Contact Dermatitis Triggered by Topical Antibiotic Ointment.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Topical antibiotic ointments are widely prescribed for infection prophylaxis after surgery and trauma, yet they are an important cause of allergic contact dermatitis. Autoeczematization, or id reaction, refers to secondary eczematous eruptions that arise at sites distant from a primary localized inflammatory focus. We report a 42-year-old man who developed generalized exudative erythematous papules after application of Baramycin® (bacitracin and fradiomycin sulfate) ointment to an erosion on his right lower leg treated for cellulitis. Despite improvement of systemic inflammatory markers, well-demarcated erythema confined to the area of ointment and dressing use, accompanied by widespread papules on the trunk, face, and extremities, persisted. Delayed patch testing could have been performed after clinical improvement, but the patient was lost to follow-up, and the clinical course strongly suggested allergic contact dermatitis with secondary autoeczematization. Discontinuation of Baramycin® and initiation of topical clobetasol propionate led to the gradual resolution of the primary lesion and rapid improvement of distant eruptions. This case underscores the need to consider autoeczematization in patients presenting with diffuse eczematous eruptions following the use of topical antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.